Defendant Name: Lode B. Debrabandere

Defendant Type: Individual

Initial Case Details

Legal Case Name SEC v. Osiris Therapeutics, Inc.; Phillip R. Jacoby, Jr.; Gregory I. Law; Lode B. Debrabandere; and Boddy Dwayne Montgomery
First Document Date 02-Nov-2017
Initial Filing Format Civil Proceeding
Case Number 17-cv-03230
Allegation Type Issuer Reporting and Disclosure
Federal District Court Maryland, District of Maryland

Affiliations

Violations Alleged

Exchange Act
• Sec 10(b) + Rule 10b-5
• Rule 13a-14
• Sec 13(b)(5)
Securities Act
• Sec 17(a) (Not specified)
Other
• Sec 304(a) Sarbanes-Oxley Act
• Rules 13b2-1, 13b2-2 Exchange Act

Related Violations Alleged

Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 10(b) + Rule 10b-5 of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Sec 10(b) + Rule 10b-5 of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Rule 12b-20 of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 13(a) of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Sec 13(a) of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Rule 13a-1 of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Rule 13a-1 of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Rule 13a-11 of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Rule 13a-11 of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Rule 13a-13 of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Rule 13a-13 of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have controlled Osiris Therapeutics, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act.
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 17(a)(1) of the Securities Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 17(a)(2) of the Securities Act (willfully/knowingly).
Lode B. Debrabandere is alleged to have aided and abetted Osiris Therapeutics, Inc.'s violation of Sec 17(a)(3) of the Securities Act (willfully/knowingly).

Resolutions

First Resolution Date
Headline Total Penalty and Disgorgement $1,763,966

Related Documents:

comp-pr2017-207 02-Nov-2017 Complaint
Complaint: Jury Trial Demanded
court_doc269_17-cv-03230 23-Nov-2022 Court Docket Document
Stipulation of Dismissal of Defendant Lode Debrabandere

Other Defendants in Action:

Phillip R. Jacoby, Jr.
Gregory I. Law
Bobby Dwayne Montgomery
Osiris Therapeutics, Inc.

Related Actions:

In the Matter of Philip R. Jacoby, Jr., CPA
Phillip R. Jacoby, Jr.